Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate

Br J Pharmacol. 1998 May;124(1):1-3. doi: 10.1038/sj.bjp.0701837.

Abstract

The antagonist activity of N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate (N6MABP) has been examined at the phospholipase C-coupled P2Y1 receptor of turkey erythrocyte membranes. N6MABP antagonized 2MeSATP-stimulated inositol phosphate hydrolysis with a potency approximately 20 fold greater than the previously studied parent molecule, adenosine 3',5'-bisphosphate. The P2Y1 receptor antagonism observed with N6MABP was competitive as revealed by Schild analysis (pK(B) = 6.99 +/- 0.13). Whereas N6MABP was an antagonist at the human P2Y1 receptor, no antagonist effect of N6MABP was observed at the human P2Y2, human P2Y4 or rat P2Y6 receptors.

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives*
  • Adenosine Diphosphate / pharmacology
  • Animals
  • Erythrocyte Membrane / drug effects
  • Erythrocyte Membrane / metabolism
  • Humans
  • Purinergic P2 Receptor Antagonists*
  • Rats
  • Receptors, Purinergic P2Y1
  • Tumor Cells, Cultured
  • Turkeys

Substances

  • N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate
  • P2RY1 protein, human
  • P2ry1 protein, rat
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2Y1
  • Adenosine Diphosphate